CASI Pharmaceuticals (CASIF) Net Income Attributable to Noncontrolling Interests (2022 - 2023)
CASI Pharmaceuticals (CASIF) posted Net Income Attributable to Noncontrolling Interests of -$129,000 for Q4 2023, compared with -$6.38 million a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Net Income Attributable to Noncontrolling Interests (2022 - 2023) Analysis & Trends
For FY2023, CASI Pharmaceuticals' Net Income Attributable to Noncontrolling Interests came in at -$3.22 million.
- In prior years, CASI Pharmaceuticals' Net Income Attributable to Noncontrolling Interests was -$10.6 million in FY2022, -$88,000 in FY2021 and -$331,000 in FY2020.
- The Q4 2023 figure stands as the highest quarterly Net Income Attributable to Noncontrolling Interests in data going back to Q1 2022.
- According to Business Quant data, Net Income Attributable to Noncontrolling Interests for the three prior quarters was -$746,000 (Q3 2023), -$1.79 million (Q2 2023) and -$559,000 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -129,000.00 |
| Sep 30, 2023 | -746,000.00 |
| Jun 30, 2023 | -1.79 Mn |
| Mar 31, 2023 | -559,000.00 |
| Dec 31, 2022 | -6.38 Mn |
| Sep 30, 2022 | -2.07 Mn |
| Jun 30, 2022 | -1.80 Mn |
| Mar 31, 2022 | -344,000.00 |
API Access
CASI Pharmaceuticals Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();